Trading Halt, page-36

I note that Leslie has been spending a fair amount of time in the USA the last couple of months - would not be surprised to see the acquisition relating to a company/drug situated in USA. Obviously the acquisition would likely be related to a cancer drug of some sort and IMU may need additional capital to progress whatever the new drug research acquisition is undertaking as well as upping the ante on IMU's current portfolio of trials and research. Hopefully capital raise is north of 2.5 cents. Can't imagine that this will be negative news as they would not undertake this acquisition unless there was a very clear purpose and prospect for it. All just speculation at this stage - time will tell.